series-a
Stage
2
Investors
About
Inozyme Therapeutics develops treatments for rare genetic disorders affecting mineral metabolism, focusing on precision therapeutics to address underlying disease causes.
Explore Inozyme's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.